Literature DB >> 31423265

Effect of the miR-96-5p inhibitor and mimic on the migration and invasion of the SW480-7 colorectal cancer cell line.

Pei Yuan He1, Wai Kien Yip2, Mohd Faisal Jabar3, Norhafizah Mohtarrudin2, Noraini Mohd Dusa4, Heng Fong Seow2.   

Abstract

The objectives of the present study were to identify the aberrant expression of microRNA (miRNA) in colorectal carcinoma (CRC) tissues from published miRNA profiling studies and to investigate the effects of the identified miRNA inhibitor and mimic miR-96-5p on CRC cell migration and invasion. The altered expression of the regulators of cytoskeleton mRNA in miR-96-5p inhibitor-transfected cells was determined. The miR-96-5p expression level in five CRC cell lines, HCT11, CaCo2, HT29, SW480 and SW620, and 26 archived paraffin-embedded CRC tissues were also investigated by reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR). Cell viability in response to the miR-96-5p inhibitor and mimic transfections was determined by an MTT assay. A Matrigel invasion assay was conducted to select the invasive subpopulation designated SW480-7, by using the parental cell line SW480. The effects of miR-96-5p mimic- or inhibitor-transfected SW480-7 cells on cell migration and invasion were evaluated using the Transwell and Matrigel assays, and the change in expression of the regulators of cytoskeleton mRNAs was identified by Cytoskeleton Regulators RT2-Profiler PCR array followed by validation with RT-qPCR. CRC tissues exhibited a significant increase in miR-96-5p expression, compared with their matched normal adjacent tissues, indicating an oncogenic role for miR-96-5p. The results demonstrated that the miR-96-5p inhibitor decreased the migration of SW480-7 cells, but had no effect on invasion. This may be due to the promotion of cell invasion by Matrigel, which counteracts the blockade of cell invasion by the miR-96-5p inhibitor. The miR-96-5p mimic enhanced SW480-7 cell migration and invasion, as expected. It was determined that there was a >2.5 fold increase in the expression of genes involved in cytoskeleton regulation, myosin light chain kinase 2, pleckstrin homology like domain family B member 2, cyclin A1, IQ motif containing GTPase activating protein 2, Brain-specific angiogenesisinhibitor 1-associated protein 2 and microtubule-actin crosslinking factor 1, in miR-96-5p inhibitor-transfected cells, indicating that they are negative regulators of cell migration. In conclusion, the miR-96-5p inhibitor blocked cell migration but not invasion, and the latter may be due to the counteraction of Matrigel, which has been demonstrated to stimulate cell invasion.

Entities:  

Keywords:  Matrigel; colorectal cancer; cytoskeleton; invasion; microRNA-96-5p; migration

Year:  2019        PMID: 31423265      PMCID: PMC6607361          DOI: 10.3892/ol.2019.10492

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  54 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

3.  MicroRNA-183 family conservation and ciliated neurosensory organ expression.

Authors:  Marsha L Pierce; Michael D Weston; Bernd Fritzsch; Harrison W Gabel; Gary Ruvkun; Garrett A Soukup
Journal:  Evol Dev       Date:  2008 Jan-Feb       Impact factor: 1.930

4.  Phosphorylation of ERM proteins at filopodia induced by Cdc42.

Authors:  N Nakamura; N Oshiro; Y Fukata; M Amano; M Fukata; S Kuroda; Y Matsuura; T Leung; L Lim; K Kaibuchi
Journal:  Genes Cells       Date:  2000-07       Impact factor: 1.891

5.  Diagnostic and prognostic microRNAs in stage II colon cancer.

Authors:  Troels Schepeler; Jørgen T Reinert; Marie S Ostenfeld; Lise L Christensen; Asli N Silahtaroglu; Lars Dyrskjøt; Carsten Wiuf; Frank J Sørensen; Mogens Kruhøffer; Søren Laurberg; Sakari Kauppinen; Torben F Ørntoft; Claus L Andersen
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

6.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

7.  Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components.

Authors:  S Vukicevic; H K Kleinman; F P Luyten; A B Roberts; N S Roche; A H Reddi
Journal:  Exp Cell Res       Date:  1992-09       Impact factor: 3.905

8.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

Authors:  E Bandrés; E Cubedo; X Agirre; R Malumbres; R Zárate; N Ramirez; A Abajo; A Navarro; I Moreno; M Monzó; J García-Foncillas
Journal:  Mol Cancer       Date:  2006-07-19       Impact factor: 27.401

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis.

Authors:  Stefan Cikos; Alexandra Bukovská; Juraj Koppel
Journal:  BMC Mol Biol       Date:  2007-12-20       Impact factor: 2.946

View more
  7 in total

1.  MiR-96 promotes apoptosis of nucleus pulpous cells by targeting FRS2.

Authors:  Xiaoxia Yang; Hengping Liu; Qingfeng Zhang; Kan Liu; Dong Yu; Yi Zhang; Zongting Shi
Journal:  Hum Cell       Date:  2020-06-23       Impact factor: 4.174

2.  miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1.

Authors:  Xiaoqin Luo; Xian He; Xing Liu; Lunkun Zhong; Wenjian Hu
Journal:  Onco Targets Ther       Date:  2020-07-30       Impact factor: 4.147

3.  MicroRNA-96-5p Facilitates the Viability, Migration, and Invasion and Suppresses the Apoptosis of Cervical Cancer Cells byNegatively Modulating SFRP4.

Authors:  Huiling Zhang; Ruxin Chen; Jinyan Shao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis.

Authors:  Caifeng Yue; Jierong Chen; Ziyue Li; Laisheng Li; Jugao Chen; Yunmiao Guo
Journal:  J Exp Clin Cancer Res       Date:  2020-11-12

5.  An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity.

Authors:  Morteza Gholami; Marzieh Zoughi; Bagher Larijani; Mahsa M Amoli; Milad Bastami
Journal:  Cancer Med       Date:  2020-10-18       Impact factor: 4.452

Review 6.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

7.  Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis.

Authors:  Ping Zhou; Tongdao Xu; Hao Hu; Fei Hua
Journal:  Int J Endocrinol       Date:  2021-10-26       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.